Outlook Therapeutics, Inc. announced a private placement of 714,286 shares at a price of $7 per share for the gross proceeds of $5,000,002 and accompanying warrant to purchase one and a half shares of common stock on April 15, 2024. The warrants have an exercise price of $7.70 per share of common stock and will expire on April 15, 2029. The transaction included participation from returning investor,
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.67 USD | +0.13% | +12.96% | -2.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.66% | 180M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC